Q1 Earnings Forecast for OPCH Issued By Barrington Research

Option Care Health, Inc. (NASDAQ:OPCH) – Investment analysts at Barrington Research increased their Q1 2025 earnings estimates for shares of Option Care Health in a note issued to investors on Tuesday, January 14th. Barrington Research analyst M. Petusky now forecasts that the company will post earnings per share of $0.22 for the quarter, up from their previous estimate of $0.20. Barrington Research currently has a “Outperform” rating and a $33.00 target price on the stock. The consensus estimate for Option Care Health’s current full-year earnings is $1.21 per share. Barrington Research also issued estimates for Option Care Health’s Q2 2025 earnings at $0.30 EPS, Q3 2025 earnings at $0.32 EPS, Q4 2025 earnings at $0.36 EPS, FY2025 earnings at $1.20 EPS and FY2026 earnings at $1.42 EPS.

A number of other brokerages also recently issued reports on OPCH. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and increased their target price for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. Jefferies Financial Group cut Option Care Health from a “buy” rating to a “hold” rating and cut their price objective for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. JMP Securities restated a “market outperform” rating and set a $30.00 target price (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. The Goldman Sachs Group cut shares of Option Care Health from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $38.00 to $27.00 in a research note on Monday, November 4th. Finally, Truist Financial decreased their price objective on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $29.86.

Option Care Health Trading Down 0.5 %

NASDAQ OPCH opened at $29.16 on Thursday. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $4.96 billion, a P/E ratio of 24.50, a P/E/G ratio of 2.44 and a beta of 1.31. Option Care Health has a 52-week low of $21.39 and a 52-week high of $34.63. The firm has a 50-day moving average price of $23.57 and a 200 day moving average price of $27.72.

Insider Activity at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The stock was purchased at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the transaction, the director now directly owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.64% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Option Care Health

Hedge funds have recently bought and sold shares of the stock. American Century Companies Inc. boosted its stake in shares of Option Care Health by 0.5% during the second quarter. American Century Companies Inc. now owns 1,154,215 shares of the company’s stock valued at $31,972,000 after acquiring an additional 5,614 shares during the last quarter. Federated Hermes Inc. lifted its holdings in Option Care Health by 5.5% in the 2nd quarter. Federated Hermes Inc. now owns 20,621 shares of the company’s stock valued at $571,000 after purchasing an additional 1,073 shares in the last quarter. Oppenheimer Asset Management Inc. boosted its stake in shares of Option Care Health by 15.4% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 65,075 shares of the company’s stock worth $1,803,000 after purchasing an additional 8,695 shares during the last quarter. Envestnet Asset Management Inc. grew its holdings in shares of Option Care Health by 2.8% during the second quarter. Envestnet Asset Management Inc. now owns 231,315 shares of the company’s stock worth $6,407,000 after buying an additional 6,283 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA acquired a new position in shares of Option Care Health in the second quarter valued at approximately $68,003,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.